Could organ-on-a-chip technology help identify drug failures before clinical trials? Jim Corbett of Emulate discusses the ...
Two cancer drugs appeared almost identical in conventional screening, but a new 3D Cell Painting method exposed striking ...
Jim Corbett has held leadership roles across biotechnology, medical imaging, analytical instruments and in vitro diagnostics.
Researchers have found that the TRPV1 pain receptor responds differently to individual stimuli, revealing functional ...
Two experimental compounds derived from a phase II metabolite have demonstrated improved anti-inflammatory activity in ...
MSA and Parkinson's share the same protein pathology, yet MSA progresses far faster. Could earlier detection reveal why and ...
PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...
A gene responsible for producing a critical enzyme in inflammatory signalling has been identified after more than 30 years, ...
A hybrid microrobotic platform combining living bacteria, nanoparticles and targeted chemotherapy has achieved 82.4 percent ...
TechBio firm WhiteLab Genomics has closed a $26 million Series B round to expand in vivo validation of its AI-designed ...
Researchers at Nagoya University have identified BCAT1, an enzyme involved in proline supply for collagen synthesis, as a ...
Cambridge biotech bit.bio has released ioAstrocytes 2.0, a genetically matched human astrocyte model designed to support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results